Literature DB >> 20080764

AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.

Markus Kalla1, Anne Schmeinck, Martin Bergbauer, Dagmar Pich, Wolfgang Hammerschmidt.   

Abstract

EBV, a member of the herpes virus family, is a paradigm for human tumor viruses and a model of viral latency amenable for study in vitro. It induces resting human B lymphocytes to proliferate indefinitely in vitro and initially establishes a strictly latent infection in these cells. BZLF1, related to the cellular activating protein 1 (AP-1) family of transcription factors, is the viral master gene essential and sufficient to mediate the switch to induce the EBV lytic phase in latently infected B cells. Enigmatically, after infection BZLF1 is expressed very early in the majority of primary B cells, but its early expression fails to induce the EBV lytic phase. We show that the early expression of BZLF1 has a critical role in driving the proliferation of quiescent naïve and memory B cells but not of activated germinal center B cells. BZLF1's initial failure to induce the EBV lytic phase relies on the viral DNA at first being unmethylated. We have found that the eventual and inevitable methylation of viral DNA is a prerequisite for productive infection in stably, latently infected B cells which then yield progeny virus lacking cytosine-phosphatidyl-guanosine (CpG) methylation. This progeny virus then can repeat EBV's epigenetically regulated, biphasic life cycle. Our data indicate that the viral BZLF1 protein is crucial both to establish latency and to escape from it. Our data also indicate that EBV has evolved to appropriate its host's mode of methylating DNA for its own epigenetic regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20080764      PMCID: PMC2818922          DOI: 10.1073/pnas.0911948107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.

Authors:  W Hammerschmidt; B Sugden
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

2.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.

Authors:  K Takada; N Shimizu; S Sakuma; Y Ono
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

4.  DNA of herpes simplex virus is not a substrate for methylation in vivo.

Authors:  M Low; J Hay; H M Keir
Journal:  J Mol Biol       Date:  1969-11-28       Impact factor: 5.469

5.  The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.

Authors:  E A Holley-Guthrie; E B Quinlivan; E C Mar; S Kenney
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

Review 6.  Epstein-Barr virus: 40 years on.

Authors:  Lawrence S Young; Alan B Rickinson
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

7.  trans-acting requirements for replication of Epstein-Barr virus ori-Lyt.

Authors:  E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

8.  Identification of the 12-O-tetradecanoylphorbol-13-acetate-responsive enhancer of the MS gene of the Epstein-Barr virus.

Authors:  Q Liu; W C Summers
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

9.  The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.

Authors:  G Urier; M Buisson; P Chambard; A Sergeant
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

10.  Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.

Authors:  P J Farrell; D T Rowe; C M Rooney; T Kouzarides
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

View more
  89 in total

1.  The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.

Authors:  Markus Kalla; Christine Göbel; Wolfgang Hammerschmidt
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

2.  Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Eric Johannsen
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

3.  Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.

Authors:  Nicolae Balan; Kay Osborn; Alison J Sinclair
Journal:  J Gen Virol       Date:  2015-12-11       Impact factor: 3.891

4.  Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation.

Authors:  E K Hoebe; C Wille; E S Hopmans; A R Robinson; J M Middeldorp; S C Kenney; A E Greijer
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

Review 5.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

6.  B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferation.

Authors:  Siva Koganti; Amanda de la Paz; Alexandra F Freeman; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

7.  (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.

Authors:  Sufang Liu; Hongde Li; Min Tang; Ya Cao
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

8.  Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.

Authors:  Stefanie Iskra; Markus Kalla; Henri-Jacques Delecluse; Wolfgang Hammerschmidt; Andreas Moosmann
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 9.  An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle.

Authors:  Adityarup Chakravorty; Bill Sugden; Eric C Johannsen
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

10.  Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.

Authors:  Eri Seto; Andreas Moosmann; Sebastian Grömminger; Nicole Walz; Adam Grundhoff; Wolfgang Hammerschmidt
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.